Recruiting NCT07634640
Hearts on Fire: Targeting Inflammation in Heart Failure With Preserved Ejection Fraction
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Ferumoxytol infusion.
- Who it may be relevant to
- Registry conditions: Heart Failure With Preserved Ejection Fraction (HFPEF). Basic parameters: 18 years — 85 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Omega-3 Fatty Acids and Myocardial Inflammation in HFpEF: Preliminary Data and Next Steps
Overview
Subjects undergo a gadolinium-based CMR followed by an iron infusion and then a repeat CMR in 72 hours
Interventions
- Drug Ferumoxytol infusion
Ferumoxytol infusion followed by cardiac MRI
Primary outcome measures
- detection of inflammation [Time frame: 72 hours]
Eligibility criteria
Inclusion criteria
- HFpEF
Exclusion criteria
- Renal insufficiency
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Other
Study locations
United States · 1 center
- University of Florida — Gainesville
Identifiers
NCT: NCT07634640 · 202300847 · 26BIPA1622606